Literature DB >> 8935711

The influence of hyperthyroidism on beta-adrenoceptor-mediated relaxation of isolated small mesenteric arteries.

J Zwaveling1, E A Winkler Prins, M Pfaffendorf, P A van Zwieten.   

Abstract

We investigated the influence of hyperthyroidism on relaxant responses of small mesenteric resistance arteries to beta-adrenoceptor agonists and to compounds stimulating the corresponding second-messenger system. Hyperthyroidism was induced by feeding rats for 28 days with 5 mg/kg L-thyroxine (T4)-containing rat chow. This treatment produced a stable hyperthyroid state, as indicated by several biochemical/metabolic and haemodynamic parameters. Preparations of small mesenteric arteries were mounted in an isometric wire myograph. Subsequently, concentration-effect curves were determined for isoproterenol, noradrenaline and salbutamol as well as for forskolin, dibutyryl-cAMP and theophylline. We also determined concentration-effect curves to the beta-adrenoceptor agonists in the presence of ICI 118,551 and CGP 20712A (i.e., in the presence of a selective beta 2- and beta 1-adrenoceptor antagonist, respectively). Apparent pA2-values were calculated to determine which beta-adrenoceptor subtype causes vasodilation. These experiments indicate that beta-adrenoceptor-mediated vasodilation involves both beta 1- and beta 2-adrenoceptors in mesenteric resistance vessels of both hyperthyroid and control rats. In our experiments hyperthyroidism has a sensitizing influence on vascular responses induced by the beta-adrenoceptor agonist isoproterenol and the selective beta 2-adrenoceptor agonist salbutamol. Sensitization to isoproterenol was abolished in the presence of ICI 118,551, whereas it was emphasized in the presence of CGP 20712A. Although this was not fully supported by the results obtained with noradrenaline, these results indicate that the sensitization to beta-adrenoceptor agonists is probably limited to the beta 2-adrenoceptor/G-protein complex and not associated with alterations of the corresponding second messenger system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8935711     DOI: 10.1007/bf00261441

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  16 in total

1.  Mechanical properties of vascular smooth muscle cells in situ.

Authors:  M J Mulvany; W Halpern
Journal:  Nature       Date:  1976-04-15       Impact factor: 49.962

2.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

Authors:  M J Mulvany; W Halpern
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

3.  Effects of thyroid hormone on beta-adrenergic responsiveness of aging cardiovascular systems.

Authors:  G Tsujimoto; K Hashimoto; B B Hoffman
Journal:  Am J Physiol       Date:  1987-03

4.  A unique pressor response to isoprenaline in the pithed rat during triiodo-L-thyronine(T3)-induced hyperthyroidism.

Authors:  G Tsujimoto; K Hashimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

Review 5.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

6.  Profile of beta-adrenoceptors in femoral, superior mesenteric and renal vascular beds of dogs.

Authors:  N Taira; Y Yabuuchi; S Yamashita
Journal:  Br J Pharmacol       Date:  1977-04       Impact factor: 8.739

7.  Steady-state levels of G-proteins and beta-adrenergic receptors in rat fat cells. Permissive effects of thyroid hormones.

Authors:  M Ros; J K Northup; C C Malbon
Journal:  J Biol Chem       Date:  1988-03-25       Impact factor: 5.157

8.  Additional evidence against universal modulation of beta-adrenoceptor responses by excessive thyroxine.

Authors:  S E Taylor
Journal:  Br J Pharmacol       Date:  1983-04       Impact factor: 8.739

9.  Thyroxine treatment of aged or young rats demonstrates that vascular responses mediated by beta-adrenoceptor subtypes can be differentially regulated.

Authors:  S R O'Donnell; J C Wanstall
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

10.  Beta-adrenoceptor antagonism and the hyperthyroid rat heart.

Authors:  G Amos; D Kerr; C Sernia; L Brown
Journal:  J Cardiovasc Pharmacol       Date:  1994-08       Impact factor: 3.105

View more
  4 in total

1.  Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries.

Authors:  Ana M Briones; Craig J Daly; Francesc Jimenez-Altayo; Sonia Martinez-Revelles; Jose M Gonzalez; John C McGrath; Elisabet Vila
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

2.  Beta2-adrenoceptors and non-beta-adrenoceptors mediate effects of BRL37344 and clenbuterol on glucose uptake in soleus muscle: studies using knockout mice.

Authors:  Robert A Ngala; Jacqueline O'Dowd; Steven J Wang; Claire Stocker; Michael A Cawthorne; Jonathan R S Arch
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

3.  Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and beta2-adrenoceptor mechanisms.

Authors:  R A Ngala; J O'Dowd; S J Wang; A Agarwal; C Stocker; M A Cawthorne; J R S Arch
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

4.  Beta-adrenergic receptors are expressed across diverse cancers.

Authors:  Steven L Rains; Clarissa N Amaya; Brad A Bryan
Journal:  Oncoscience       Date:  2017-08-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.